135 related articles for article (PubMed ID: 8395583)
1. Agonists for neuropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite actions on rat nodose neuron calcium currents.
Wiley JW; Gross RA; MacDonald RL
J Neurophysiol; 1993 Jul; 70(1):324-30. PubMed ID: 8395583
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism.
Wiley JW; Gross RA; Lu YX; Macdonald RL
J Neurophysiol; 1990 Jun; 63(6):1499-507. PubMed ID: 2358888
[TBL] [Abstract][Full Text] [Related]
3. The peptide CGRP increases a high-threshold Ca2+ current in rat nodose neurones via a pertussis toxin-sensitive pathway.
Wiley JW; Gross RA; MacDonald RL
J Physiol; 1992 Sep; 455():367-81. PubMed ID: 1336552
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
6. The cyclic AMP-dependent protein kinase catalytic subunit selectively enhances calcium currents in rat nodose neurones.
Gross RA; Uhler MD; Macdonald RL
J Physiol; 1990 Oct; 429():483-96. PubMed ID: 2177506
[TBL] [Abstract][Full Text] [Related]
7. Regulation by GTP and its stable thiol derivatives of calcium current components in rat nodose ganglion neurons.
Gross RA; Wiley JW; Ryan-Jastrow T; Macdonald RL
Mol Pharmacol; 1990 Apr; 37(4):546-53. PubMed ID: 2157961
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
Fu LY; Acuna-Goycolea C; van den Pol AN
J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Browning KN; Travagli RA
J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vasoconstriction and Ca2+ currents mediated by neuropeptide Y Y2 receptors.
Lewis CJ; Evans RJ; Neild TO
J Smooth Muscle Res; 1999; 35(5-6):147-56. PubMed ID: 10733151
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcium currents in cultured myenteric neurons by neuropeptide Y: evidence for direct receptor/channel coupling.
Hirning LD; Fox AP; Miller RJ
Brain Res; 1990 Nov; 532(1-2):120-30. PubMed ID: 1704288
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y and pancreatic polypeptide reduce calcium currents in acutely dissociated neurons from adult rat superior cervical ganglia.
Foucart S; Bleakman D; Bindokas VP; Miller RJ
J Pharmacol Exp Ther; 1993 May; 265(2):903-9. PubMed ID: 8098766
[TBL] [Abstract][Full Text] [Related]
15. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat.
Bleakman D; Harrison NL; Colmers WF; Miller RJ
Br J Pharmacol; 1992 Oct; 107(2):334-40. PubMed ID: 1358389
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents.
Gross RA; Moises HC; Uhler MD; Macdonald RL
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7025-9. PubMed ID: 1976250
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y receptors differentially modulate G-protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons.
Sun QQ; Huguenard JR; Prince DA
J Physiol; 2001 Feb; 531(Pt 1):67-79. PubMed ID: 11179392
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
Yu XJ; Moskowitz MA
Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
[TBL] [Abstract][Full Text] [Related]
20. Multiple neuropeptide Y receptors regulate K+ and Ca2+ channels in acutely isolated neurons from the rat arcuate nucleus.
Sun L; Miller RJ
J Neurophysiol; 1999 Mar; 81(3):1391-403. PubMed ID: 10085364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
